Patent details
EP2817011 Title: TREATMENT OF CANCER
Basic Information
- Publication number:
- EP2817011
- PCT Application Number:
- US2013027091
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP137511887
- PCT Publication Number:
- WO2013126539
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF CANCER
- French Title of Invention:
- TRAITEMENT DU CANCER
- German Title of Invention:
- KREBSBEHANDLUNG
- SPC Number:
Dates
- Filing date:
- 21/02/2013
- Grant date:
- 05/01/2022
- EP Publication Date:
- 31/12/2014
- PCT Publication Date:
- 29/08/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/01/2022
- EP B1 Publication Date:
- 05/01/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/02/2022
- Expiration date:
- 21/02/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/12/2021
- Name:
- ImmunoGenesis, Inc.
- Address:
- 909 Fannin, Suite 2000, Houston TX 77010, United States (US)
Inventor
- Name:
- KROLL, Stewart
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261601438 P
- Priority Date:
- 21/02/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361756419 P
- Priority Date:
- 24/01/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/664; A61K 31/675; A61K 31/7068; A61P 35/00; A61K 31/685;
Publication
European Patent Bulletin
- Issue number:
- 202201
- Publication date:
- 05/01/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|